期刊文献+

地西他滨增强allo-NK细胞杀伤白血病干细胞敏感性研究 预览 被引量:3

Decitabine Enhances the Sensitivity of Leukemia Stem Cell to Allo-NK Cell-Mediated Killing
在线阅读 下载PDF
收藏 分享 导出
摘要 目的:探讨地西他滨增强allo-NK细胞杀伤白血病干细胞(LSC)的作用及其机制。方法:应用免疫磁珠法从KG1a细胞中分选LSC。从健康供者的外周血分离纯化同种异体反应性自然杀伤(allo-reactive natural killer,a1-Io-NK)细胞;LDH法检测allo-NK细胞对LSC的杀伤作用,流式细胞术检测allo-NK细胞诱导LSC凋亡及LSC表面NKG2D配体MICA/B和ULBP1-3的表达。结果:地西他滨10μmol/L处理LSC 24 h后,allo-NK细胞对LSC的杀伤率明显增高,在效靶比为5:1、10:1、20:1时分别为(60.52%±3.52%vs 22.08%±2.07%、73.93%±2.33%vs 28.99%±3.13%、83.08%±1.32%vs 36.44%±2.40%),差异有统计学意义(P〈0.05);地西他滨10μmol/L处理LSC 24 h后,在效靶比为10:1时,allo-NK细胞诱导LSC的凋亡率为7.84%±0.34%,明显高于LSC未处理组(3.33%±0.64%),差异有统计学意义(P〈0.05);地西他滨10μmol/L处理LSC 24 h后,LSC表面NKG2D配体(MICA/B、ULBP1、ULBP2、ULBP3)的表达上调,高于未处理组,差异有统计学意义(P〈0.05)。结论:地西他滨可能通过上调NKG2D配体增强allo-NK细胞对LSC的杀伤作用。 Objective;To investigate the allo-NK cell-mediated killing effect enhanced by decitabine on leukemia stem cells(LSC) and the underlying mechanisms.Methods;LSC were separated from KG1 a cells by using immunomagnetic beads.Allo-NK cells were isolated and purified from PBMC of healthy donors.Cytotoxicity of alloNK cells against LSC were measured by LDH releasing assay.The apoptosis induced by allo-NK cells in LSC and the expressions of NKG2 D ligands including MICA/B and ULBP1-3 on LSC were detected by flow cytometry.Results:The killing rate of allo-NK cells to LSC treated with 10 μmol/L decitabine for 24 hours was significant higher than that to LSC without treatment 60.52%±3.52%vs22.08%±2.07%,73.93%±2.33%vs 28.99%±3.13%,83.08%± 1.32%vs 36.44%±2.40%,respectively) at the effector-target ratios of 5:1,10:1,20:1(P〈 0.05).At the effector-target ratio of 10:1,decitabine significantly enhanced the apoptosis of LSC induced by allo-NK cells(7.84%±0.34%vs 3.33%±0.64%)(P〈0.05).The expressions of NKG2 D ligands(MICA/B,ULBP1,ULBP2,ULBP3) on LSC treated with decitabine 10 μmol/L for 24 hours were significantly increased(P〈 0.05).Conclusion;Decitabine may enhance the allo-NK cell-mediated killing effects on LSC by up-regulation of the expressions of NKG2 D ligands on LSC.
作者 李倩 魏姗姗 李劲高 陈少贤 陈景 黄晖婷 彭琪 夏平方 佘妙容 w LI Qian1 , WEI Shan-Shan2, LI Jin-Gao3, CHEN Shao-Xian4, CHEN Jing4, HUANG Hui-Ting1 , PENG Qi1 , XIA Ping-Fang1, SHE Miao-Rong1.(1Department of Hematology, Guangdong People's Hospital ( Guangdong Academy of Medical Sciences), Guangzhou 510080, Guang- dong Province, China ; 2 Department of Hematology, Jingmen Municipal First People' s Hospital, Jingmen 448000, Hubei Province, China; 3Department of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China ; 4 Department of Pathophysiology, Guangdong People Hospital ( Guangdong Academy of Medical Sciences ), Guangzhou 510080, Guangdong Province, China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2017年第1期85-89,共5页 Journal of Experimental Hematology
基金 国家自然科学基金(81370664) 广东省科技厅科技攻关计划项目(2013B021800188),广东省科技厅科技攻关计划项目(2013B021800094)
关键词 地西他滨 白血病干细胞 allo-NK细胞 NKG2D配体 decitabine leukemia stem cell allo-NK cell NKG2D ligand
作者简介 通讯作者:佘妙容,教授,博士生导师.E—mail:SMRS07@163.com
  • 相关文献

参考文献3

二级参考文献33

共引文献10

同被引文献21

引证文献3

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈